Stay updated on NC410 Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the displayed study record history remains unchanged.SummaryDifference0.1%

- Check23 days agoChange DetectedAn NIH-wide notice was added announcing updates and FAQs about the agency’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.6%

- Check30 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe footer revision identifier updates from v3.7.0 to v3.7.1, with no change to the displayed study record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe revision history now shows a new entry for v3.7.0, replacing the previous v3.6.6. This reflects a backend or UI update to the page's revision-tracking rather than changes to the study data.SummaryDifference0.1%

- Check79 days agoChange DetectedThe history now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This is a metadata update with no impact on the study information.SummaryDifference0.1%

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.